Imagine trying to judge how much damage is done to a car by looking at its engine, but the engine is covered in thick grease. That is exactly what happens when doctors try to use standard blood tests to check for liver scarring in patients who also have fatty liver. This study looked at treatment-naive patients with chronic hepatitis B to see if fat in the liver messed up the results of common scores like APRI and FIB-4.
The results were stark. When patients did not have fatty liver, the APRI score correctly identified severe scarring about 90% of the time. However, when moderate-to-severe fat was present, that accuracy plummeted to less than 50%. The same drop happened for the FIB-4 score. Even worse, the chance that a positive test actually meant severe scarring collapsed from 73% to just 23%.
This means these simple blood tests cannot be trusted for everyone. If a doctor suspects a patient has fatty liver, relying on these scores could lead to a dangerous underestimation of their liver damage. The study suggests that doctors should use different methods, like ultrasound-based imaging, instead when fat is involved to get a true picture of the liver's health.
